Creative Medical Technology (CELZ) Competitors $2.14 -0.04 (-1.83%) Closing price 06/16/2025 03:59 PM EasternExtended Trading$2.16 +0.02 (+0.93%) As of 06/16/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. NNVC, CMMB, CARA, TENX, CYTH, OVID, ENLV, GDTC, ELEV, and CASIShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include NanoViricides (NNVC), Chemomab Therapeutics (CMMB), Cara Therapeutics (CARA), Tenax Therapeutics (TENX), Cyclo Therapeutics (CYTH), Ovid Therapeutics (OVID), Enlivex Therapeutics (ENLV), CytoMed Therapeutics (GDTC), Elevation Oncology (ELEV), and CASI Pharmaceuticals (CASI). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors NanoViricides Chemomab Therapeutics Cara Therapeutics Tenax Therapeutics Cyclo Therapeutics Ovid Therapeutics Enlivex Therapeutics CytoMed Therapeutics Elevation Oncology CASI Pharmaceuticals NanoViricides (NYSE:NNVC) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment, community ranking and dividends. Is NNVC or CELZ more profitable? Creative Medical Technology's return on equity of -63.05% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets NanoViricidesN/A -87.90% -78.69% Creative Medical Technology N/A -63.05%-60.42% Does the media favor NNVC or CELZ? In the previous week, Creative Medical Technology had 2 more articles in the media than NanoViricides. MarketBeat recorded 3 mentions for Creative Medical Technology and 1 mentions for NanoViricides. Creative Medical Technology's average media sentiment score of -0.27 beat NanoViricides' score of -1.00 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Overall Sentiment NanoViricides Negative Creative Medical Technology Neutral Which has preferable earnings and valuation, NNVC or CELZ? Creative Medical Technology has higher revenue and earnings than NanoViricides. NanoViricides is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanoViricidesN/AN/A-$8.29M-$0.70-2.07Creative Medical Technology$14K395.29-$5.29M-$3.81-0.56 Do institutionals and insiders have more ownership in NNVC or CELZ? 10.3% of NanoViricides shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 4.6% of NanoViricides shares are held by insiders. Comparatively, 2.8% of Creative Medical Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community favor NNVC or CELZ? Creative Medical Technology received 71 more outperform votes than NanoViricides when rated by MarketBeat users. Likewise, 68.27% of users gave Creative Medical Technology an outperform vote while only 0.00% of users gave NanoViricides an outperform vote. CompanyUnderperformOutperformNanoViricidesOutperform VotesNo VotesUnderperform Votes57100.00% Creative Medical TechnologyOutperform Votes7168.27% Underperform Votes3331.73% Which has more volatility & risk, NNVC or CELZ? NanoViricides has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 1.98, indicating that its share price is 98% more volatile than the S&P 500. SummaryCreative Medical Technology beats NanoViricides on 10 of the 13 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.64M$3.09B$5.52B$8.60BDividend YieldN/A1.54%5.27%4.17%P/E Ratio-0.5631.8426.5819.77Price / Sales395.29458.05399.20150.25Price / CashN/A168.6838.2534.64Price / Book0.293.367.084.68Net Income-$5.29M-$72.17M$3.21B$247.80M7 Day Performance-11.57%-3.80%-0.21%-0.45%1 Month Performance5.94%12.86%7.38%3.94%1 Year Performance-45.41%-14.23%35.11%16.00% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.4401 of 5 stars$2.14-1.8%N/A-48.6%$5.64M$14K-0.565Short Interest ↑NNVCNanoViricides0.0811 of 5 stars$1.53+0.7%N/A-23.7%$24.59MN/A-2.1220Negative NewsShort Interest ↑CMMBChemomab Therapeutics3.5474 of 5 stars$1.30-1.5%$8.50+553.8%+8.8%$24.51MN/A-1.3020Gap DownCARACara Therapeutics0.2835 of 5 starsN/A$36.00+∞N/A$24.33M$7.14M-0.2580Gap DownHigh Trading VolumeTENXTenax Therapeutics1.6551 of 5 stars$5.78-1.4%$17.50+202.8%+94.6%$23.98MN/A-2.339Positive NewsGap UpCYTHCyclo TherapeuticsN/A$0.72flat$0.95+31.8%N/A$23.72M$870.73K-0.809OVIDOvid Therapeutics4.4011 of 5 stars$0.32-3.0%$2.78+766.8%-91.2%$22.83M$548K-0.6860Gap UpHigh Trading VolumeENLVEnlivex Therapeutics3.4798 of 5 stars$0.96+2.1%$10.00+941.7%-29.5%$22.71MN/A-0.9870Positive NewsGDTCCytoMed Therapeutics2.618 of 5 stars$2.08-0.7%$5.00+141.0%+10.0%$22.70M$69.50K0.00N/AELEVElevation Oncology3.5312 of 5 stars$0.38-0.4%$3.39+784.7%-88.1%$22.67MN/A-0.4740Short Interest ↓High Trading VolumeCASICASI Pharmaceuticals4.3902 of 5 stars$1.83-2.1%$4.00+118.5%-57.2%$22.52M$31.37M-0.82180Positive NewsGap Up Related Companies and Tools Related Companies NanoViricides Alternatives Chemomab Therapeutics Alternatives Cara Therapeutics Alternatives Tenax Therapeutics Alternatives Cyclo Therapeutics Alternatives Ovid Therapeutics Alternatives Enlivex Therapeutics Alternatives CytoMed Therapeutics Alternatives Elevation Oncology Alternatives CASI Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CELZ Stock Free CELZ Stock Alerts